EU & Australia regulatory framework – EMA and EDQM structure MCQs With Answer

Introduction

EU & Australia regulatory framework – EMA and EDQM structure MCQs With Answer

This quiz set is designed for M.Pharm students preparing for the Regulatory Aspects of Drugs & Cosmetics course. It focuses on the organisational structures, core functions and procedural pathways of the European Medicines Agency (EMA) and the European Directorate for the Quality of Medicines & HealthCare (EDQM), and contrasts key elements of the Australian regulatory framework led by the Therapeutic Goods Administration (TGA). Questions probe scientific committees, centralised and national procedures, pharmacopoeial roles, Certificates of Suitability (CEPs), OMCL activities, pharmacovigilance systems and the ARTG. Use these MCQs to reinforce conceptual understanding and prepare for exams and regulatory practice.

Q1. Which body is the principal scientific committee within the European Medicines Agency responsible for opinions on human medicines?

• Committee for Veterinary Medicinal Products (CVMP)
• Committee for Medicinal Products for Human Use (CHMP)
• Pharmacovigilance Risk Assessment Committee (PRAC)
• Committee on Herbal Medicinal Products (HMPC)

Correct Answer: Committee for Medicinal Products for Human Use (CHMP)

Q2. The EDQM is an agency of which pan-European organisation?

• European Union (EU)
• European Medicines Agency (EMA)
• Council of Europe
• World Health Organization (WHO)

Correct Answer: Council of Europe

Q3. What is the primary output of the EDQM that sets legally binding quality standards for medicines across member states?

• European Pharmacopoeia
• CEPs (Certificates of Suitability)
• OMCL Test Reports
• EDQM Guidance Notes

Correct Answer: European Pharmacopoeia

Q4. Which EMA committee is specifically responsible for risk assessment and monitoring of safety issues (pharmacovigilance)?

• Committee on Advanced Therapies (CAT)
• Pediatric Committee (PDCO)
• Pharmacovigilance Risk Assessment Committee (PRAC)
• Committee for Orphan Medicinal Products (COMP)

Correct Answer: Pharmacovigilance Risk Assessment Committee (PRAC)

Q5. A Certificate of Suitability (CEP) issued by the EDQM certifies compliance of what aspect of a medicinal substance?

• Manufacturing site GMP compliance
• Compliance of a substance with a European Pharmacopoeia monograph
• Marketing authorisation dossier completeness
• Clinical trial protocol suitability

Correct Answer: Compliance of a substance with a European Pharmacopoeia monograph

Q6. Which procedure at the EMA provides a single marketing authorisation valid across all EU Member States?

• National procedure
• Decentralised procedure
• Mutual Recognition Procedure
• Centralised procedure

Correct Answer: Centralised procedure

Q7. The network of Official Medicines Control Laboratories (OMCLs) coordinated by the EDQM primarily performs which activity?

• Granting marketing authorisations
• Independent quality control testing of medicines and sampling
• Reviewing clinical trial safety data
• Issuing GMP certificates to manufacturers

Correct Answer: Independent quality control testing of medicines and sampling

Q8. Which EMA scientific committee evaluates cell-based, gene and tissue-engineered products?

• Committee for Medicinal Products for Human Use (CHMP)
• Committee on Advanced Therapies (CAT)
• Committee for Orphan Medicinal Products (COMP)
• Pediatric Committee (PDCO)

Correct Answer: Committee on Advanced Therapies (CAT)

Q9. In the EU regulatory framework, who is legally responsible for certifying that each batch of a medicinal product is manufactured in compliance with GMP before release for sale?

• Marketing Authorisation Holder (MAH)
• Qualified Person (QP)
• EDQM Inspector
• GMP Auditor

Correct Answer: Qualified Person (QP)

Q10. The Australian Therapeutic Goods Administration (TGA) maintains which registry of approved therapeutic goods?

• European Register of Medicinal Products (ERMP)
• Australian Register of Therapeutic Goods (ARTG)
• Therapeutic Goods Database of Australia (TGDA)
• National Medicines Register (NMR)

Correct Answer: Australian Register of Therapeutic Goods (ARTG)

Q11. Which EMA database collects suspected adverse reaction reports for medicines authorised in the EU?

• EudraVigilance
• EudraCT
• VigiBase
• Pharmacovigilance Hub

Correct Answer: EudraVigilance

Q12. The European Pharmacopoeia Commission is charged primarily with which responsibility?

• Issuing GMP certificates to manufacturers
• Adopting texts and monographs for the European Pharmacopoeia
• Running clinical inspections across member states
• Authorising marketing applications centrally

Correct Answer: Adopting texts and monographs for the European Pharmacopoeia

Q13. Which of the following is NOT a primary function of the EDQM?

• Developing and revising pharmacopoeial monographs
• Coordinating the OMCL network
• Granting EU marketing authorisations
• Issuing Certificates of Suitability (CEPs)

Correct Answer: Granting EU marketing authorisations

Q14. Which procedure is typically used when a company seeks simultaneous marketing authorisations in several EU countries where there is no previous authorisation?

• Decentralised procedure
• National procedure
• Centralised procedure only for generics
• Mutual Recognition Procedure

Correct Answer: Decentralised procedure

Q15. The TGA in Australia may rely on decisions or assessments from comparable overseas regulators. This approach is commonly referred to as what?

• Regulatory isolation
• International harmonisation
• Regulatory reliance
• Direct adoption

Correct Answer: Regulatory reliance

Q16. Which EMA committee issues recommendations on paediatric investigation plans and paediatric medicines?

• Pediatric Committee (PDCO)
• Committee for Orphan Medicinal Products (COMP)
• Committee on Herbal Medicinal Products (HMPC)
• Committee on Advanced Therapies (CAT)

Correct Answer: Pediatric Committee (PDCO)

Q17. What is the main purpose of the EudraGMDP database maintained by EMA?

• Record of clinical trial protocols in the EU
• Repository of GMP and good distribution practice (GMDP) inspection outcomes and manufacturing/import authorisations
• Database of marketing authorisation holders
• Pharmacovigilance signal management

Correct Answer: Repository of GMP and good distribution practice (GMDP) inspection outcomes and manufacturing/import authorisations

Q18. A CEP application to the EDQM is intended to simplify which part of a medicinal product’s regulatory submission?

• Clinical efficacy evidence
• Quality documentation concerning the active substance
• Pharmacovigilance system set-up
• Label translation and local packaging details

Correct Answer: Quality documentation concerning the active substance

Q19. Which EMA organ is responsible for overall strategic direction and budget oversight of the Agency?

• Scientific Advisory Board
• Management Board
• Executive Director alone
• Committee for Medicinal Products for Human Use (CHMP)

Correct Answer: Management Board

Q20. Within the Australian regulatory context, which document/classification determines whether a substance is prescription-only or available over the counter?

• Australian Regulatory Framework (ARF)
• Scheduling of Medicines and Poisons (Poisons Standard)
• TGA Approval Guideline
• ARTG Scheduling Index

Correct Answer: Scheduling of Medicines and Poisons (Poisons Standard)

Download